John H Leaman's Insider Trades & SAST Disclosures

John H Leaman's most recent trade in Impel Pharmaceuticals Inc was a trade of 70,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 14, 2023.

Share

Note

This is a custom search result for pattern John H Leaman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Impel Pharmaceuticals Inc	John H. Leaman	Chief Fin. & Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Feb 2023	70,000	70,000	-		-	Stock Option (right to buy)
Impel Pharmaceuticals Inc	John H. Leaman	Chief Fin. & Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Dec 2022	10,571	0	-		-	Restricted Stock Units (RSUs)
Impel Pharmaceuticals Inc	John H. Leaman	Chief Fin. & Business Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Dec 2022	10,571	10,571	-		0	Common Stock
Impel Pharmaceuticals Inc	John H. Leaman	Chief Fin. & Business Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.75 per share.	31 Dec 2022	3,627	6,944	-	3.7	13,601	Common Stock
Impel Pharmaceuticals Inc	John H. Leaman	Chief Fin. & Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Jan 2022	100,000	100,000	-		-	Stock Option (right to buy)
Impel Pharmaceuticals Inc	John H. Leaman	Chief Fin. & Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Oct 2021	10,571	10,571	-		-	Restricted Stock Units (RSUs)
Impel Pharmaceuticals Inc	John H. Leaman	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jul 2021	50,000	50,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades